Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder
Biological Psychiatry Global Open Science · 2023-10 · 3 (4) · 663-672
DOI: 10.1016/j.bpsgos.2023.01.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological Psychiatry Global Open Science, 2023-10. Verfasst von Zuoli Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical Unive…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Beijing Young Talent.
Abstract (Originalsprache)
Background
There is growing evidence that disturbances in cholesterol metabolism may be involved in major depressive disorder (MDD). However, it is not known if cholesterol metabolites present in the brain and periphery can be used to diagnose and predict an MDD patient's response to antidepressant treatment.
Methods
A total of 176 subjects (85 patients with MDD and 91 healthy control subjects) were included in this study. The expression of peripheral and brain-specific oxysterols and related gene polymorphisms were investigated in all subjects. The severity of depression was measured using the 17-item Hamilton Depression Rating Scale, 16-item Quick Inventory of Depressive Symptoms-Self-Report, and Patient Health Questionnaire-9 for all patients with MDD before and after 12 weeks of antidepressant treatment.
Results
Patients with MDD expressed higher plasma levels of 24(S)-hydroxycholesterol (24OHC) (mainly secreted from the brain) compared with healthy control subjects, and the higher levels of 24OHC were associated with 24OHC synthetase (CYP46A1) gene polymorphisms. In patients with MDD, an improved response to the 12-week antidepressant treatment was associated with a reduction of both 24OHC and 27OHC (mainly secreted from the peripheral system) levels relative to baseline levels. Nonresponders exhibited increased levels of oxysterols at the end of treatment compared with baseline. The superior reduction in oxysterol levels correlated with better outcomes from the antidepressant treatment.
Conclusions
These data suggest a potential role for oxysterols as diagnostic and treatment response-related indicators for MDD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
- Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
- Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Beijing Young Talent
Zitieren
APA
Sun, Z., Yang, J., Zhou, J., Zhou, J., Feng, L., Feng, Y., He, Y., Liu, M., Li, Y., Wang, G., & Li, R. (2023). Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder. Biological Psychiatry Global Open Science, 3(4), 663-672. https://doi.org/10.1016/j.bpsgos.2023.01.004
Vancouver
Sun Z, Yang J, Zhou J, Zhou J, Feng L, Feng Y, et al. Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder. Biological Psychiatry Global Open Science. 2023;3(4):663-672. doi:10.1016/j.bpsgos.2023.01.004
BibTeX
@article{Sun2023,
author = {Sun, Zuoli and Yang, Jian and Zhou, Jia and Zhou, Jingjing and Feng, Lei and Feng, Yuan and He, Yi and Liu, Min and Li, Yuhong and Wang, Gang and Li, Rena},
title = {Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder},
journal = {Biological Psychiatry Global Open Science},
year = {2023},
volume = {3},
number = {4},
pages = {663--672},
doi = {10.1016/j.bpsgos.2023.01.004}
}
EUVIMED